Oct 30-31,2024 in Las Vegas, Booth No: 4438

May 14-16,2024 in Geneva Switzerland, Booth No：D155 May6-17, 2024, online

Chitin health project, sounded the horn to declare war on modern diseases, become another milestone in human resistance to disease; Its role in human health has been positioned by the scientific community as a third milestone in the exploration of the mysteries of life

On December 11, 2023, The company's application for listing of Glucosamine Sulfate Sodium Chloride was accepted and registered by the National Medical Products Administration with acceptance number CYHS2360915 and registration number Y20230001033.

On September 15th, 2023, the company was issued a Drug Manufacturing License, demonstrating that the company has established a comprehensive quality assurance system capable of ensuring production and quality management activities in accordance with the current Good Manufacturing Practice (cGMP) regulations in China.

On August 17th to 18th, 2023, ZheJiang Medical Products Administration conducted an on-site inspection of the company's application for a Drug Manufacturing License. The inspection results generally meet the requirements and are approved.

Glucosamine acts like a "septum" around the joint in the body. The high density of chitosan in gold shells indicates that the "septum" becomes thinner and stiffer in some osteoarthritis patients.